Common side effects (typically mild): Injection site redness, itching, or mild irritation Temporary water retention during initial weeks Tingling or numbness in extremities (usually resolves with dose adjustment) Increased hunger (particularly with ghrelin-based peptides like ipamorelin) Mild headache during initial treatment Contraindications: Active cancer or history of cancer (growth hormone peptides can promote cell growth) Pregnancy or breastfeeding Uncontrolled diabetes Active infection (for BPC-157/TB-500 while they promote healing, treatment should begin after acute infection resolves) We require baseline blood work (including IGF-1) before prescribing any peptide and monitor your progress with follow-up labs at 8-12 weeks
The FDA has approved several medications for treating obesity, and each works a little differently
J.MilliganJ.WohlschlegelJ
More importantly, although AICAR acts on PARP-1 phosphorylation and ABCA1 protein level in the presence or absence of PARP1 treatment, the effects of AICAR could be partially attenuated by PARP-1 treatment
Begin a supplementation protocol that includes EGCG-rich green tea extract, resveratrol, melatonin, fucoidan, and kaempferol
This conjugation increases the water solubility of electrophilic substrates, facilitating their export via multidrug resistance-associated protein transporters and promoting subsequent elimination from the body
